Embree Financial Group Spdr Ser Tr Spdr S&P Biotech E Transaction History

Embree Financial Group

$664 Billion
Q2 2025

A detailed history of Embree Financial Group transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Embree Financial Group holds 3,294 shares of XBI stock, worth $281,406. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,294

Previous 4,314 23.64%

Holding current value

$281,406

Previous $350 Million 21.92%

% of portfolio

0.04%

Previous 0.06%

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	SELL	$69.8 - $85.28 $71,196 - $86,985	-1,020 Reduced 23.64%	3,294 $273 Million
Q1 2025 Apr 22, 2025	BUY	$81.1 - $94.7 $66,096 - $77,180	815 Added 23.29%	4,314 $350 Million
Q4 2024 Jan 21, 2025	SELL	$89.81 - $104.0 $36,013 - $41,704	-401 Reduced 10.28%	3,499 $315 Million
Q3 2024 Oct 18, 2024	BUY	$90.87 - $102.43 $63,699 - $71,803	701 Added 21.91%	3,900 $385 Million
Q2 2024 Aug 01, 2024	BUY	$82.22 - $94.12 $263,021 - $301,089	3,199 New	3,199 $297 Million

Others Institutions Holding XBI

# of Institutions

801

Shares Held

111M

Call Options Held

23.2M

Put Options Held

28.2M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Embree Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Embree Financial Group with notifications on news.

Account

Embree Financial Group Spdr Ser Tr Spdr S&P Biotech E Transaction History